Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ertugliflozin in Chronic Heart Failure: Cardio-renal and Diuretic Effects

NCT04438213 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04438213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04438213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ertugliflozin in Chronic Heart Failure: Cardio-renal and Diuretic Effects
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
March 10, 2021
Completion date
December 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure